2006
DOI: 10.1021/jm0505718
|View full text |Cite
|
Sign up to set email alerts
|

Trace Amine-Associated Receptor Agonists:  Synthesis and Evaluation of Thyronamines and Related Analogues

Abstract: We have previously shown that several thyronamines, decarboxylated and deiodinated metabolites of the thyroid hormone, potently activate an orphan G protein-coupled receptor in vitro (TAAR1) and induced hypothermia in vivo on a rapid time scale [Scanlan, T. S.; Suchland, K. L.; Hart, M. E.; Chiellini, G.; Huang, Y.; Kruzich, P. J.; Frascarelli, S.; Crossley, D. A.; Bunzow, J. R.; Ronca-Testoni, S.; Lin, E. T.; Hatton, D.; Zucchi, R.; Grandy, D. K. 3-Iodothyronamine is an endogenous and rapid-acting derivative … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

3
125
1

Year Published

2007
2007
2014
2014

Publication Types

Select...
8
2

Relationship

3
7

Authors

Journals

citations
Cited by 120 publications
(129 citation statements)
references
References 23 publications
3
125
1
Order By: Relevance
“…Recently, a novel family of TAARs has been identified; however, in contrast to the classical BAs, much less is known about trace amine-mediated signaling. Both TAAR1 and TAAR2 bind TA and other ligands such as iodothyronamines, with high affinity and couple to G␣ s after heterologous expression (Borowsky et al, 2001;Bunzow et al, 2001;Hart et al, 2006). Based on studies in TAAR1 knock-out mice, amphetamines also appear to be high-potency agonists at TAAR1 receptors, and TAAR1 appears to modulate catecholaminergic function, suggesting that signaling through TAARs might provide useful targets for the treatment of a variety of behavioral disorders (Wolinsky et al, 2006).…”
Section: Discussionmentioning
confidence: 99%
“…Recently, a novel family of TAARs has been identified; however, in contrast to the classical BAs, much less is known about trace amine-mediated signaling. Both TAAR1 and TAAR2 bind TA and other ligands such as iodothyronamines, with high affinity and couple to G␣ s after heterologous expression (Borowsky et al, 2001;Bunzow et al, 2001;Hart et al, 2006). Based on studies in TAAR1 knock-out mice, amphetamines also appear to be high-potency agonists at TAAR1 receptors, and TAAR1 appears to modulate catecholaminergic function, suggesting that signaling through TAARs might provide useful targets for the treatment of a variety of behavioral disorders (Wolinsky et al, 2006).…”
Section: Discussionmentioning
confidence: 99%
“…T 1 AM and other thyronamines such as 3,3Ј,5,5Ј-tetraiodothyronamine (T 4 AM), 3,3Ј,5Ј-triiodothyronamine (rT 3 AM), 3,5,3Ј-triiodothyronamine (T 3 AM), 3,5-diiodothyronamine (3,5-T 2 AM), 3,3Ј-diiodothyronamine (3,3Ј-T 2 AM), and thyronamine (T 0 AM) were synthesized according to the literature (14). Anhydrous dimethylformamide (DMF) was obtained by passing through two columns of activated molecular sieves.…”
Section: Methodsmentioning
confidence: 99%
“…Far from futile, the search for additional endogenous TAAR1 ligands has already led to the discovery of 3-iodothyronamine (T1AM) and its deiodinated relative thyronamine (T0AM), molecules that are closely related to thyroid hormone (Scanlan et al, 2004;Hart et al, 2006;Tan et al, 2007). Based on the structure activity profile compiled by Bunzow et al (2001) and the fact that the catecholamines and para-tyramine are all derivatives of the amino acid tyrosine (Y), Grandy and Scanlan conjectured that decarboxylated metabolites of thyroid hormone would be TAAR1 agonists.…”
Section: Novel Endogenous Ligands Of Vertebratementioning
confidence: 99%